CRISPR Therapeutics

ISIN CH0334081137

WKN A2AT0Z

Overview

Description

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

Show more Show less

Healthcare Biopharmaceuticals Other Biopharmaceuticals Switzerland

Financials

Key metrics

Market capitalisation, EUR	2,519.58 m
EPS, EUR	-4.03
P/B ratio	1.45
P/E ratio	-
Dividend yield	0.00%

Income statement (2024)

Revenue, EUR	34.50 m
Net income, EUR	-338.59 m
Profit margin	-981.54%

What ETF is CRISPR Therapeutics in?

There are 31 ETFs which contain CRISPR Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of CRISPR Therapeutics is the ARK Genomic Revolution UCITS ETF USD Accumulating.

Show entries

Search:

ETF	Weight	Investment focus	Holdings	TER	Fund size (in m EUR)	Return 1Y	ISIN
ARK Genomic Revolution UCITS ETF USD Accumulating	7.64%	Equity World Health Care Innovation	35	0.75%	8	-	IE000O5M6XO1
ARK Innovation UCITS ETF USD Accumulating	4.93%	Equity World Innovation	34	0.75%	36	-	IE000GA3D489
Global X Genomics & Biotechnology UCITS ETF	4.46%	Equity World Health Care Biotech	40	0.50%	7	-32.14%	IE00BM8R0N95
L&G Healthcare Breakthrough UCITS ETF USD Acc	1.41%	Equity World Health Care Innovation	67	0.49%	52	-8.52%	IE00BK5BC677
VanEck Genomics and Healthcare Innovators UCITS ETF A	1.29%	Equity World Health Care Social/Environmental Innovation	50	0.35%	4	-14.53%	IE000B9PQW54
WisdomTree BioRevolution UCITS ETF USD Acc	1.21%	Equity World Health Care Social/Environmental Biotech	88	0.45%	3	-27.59%	IE000O8KMPM1
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C	0.91%	Equity World Health Care Social/Environmental Innovation	98	0.30%	3	-13.49%	IE000KD0BZ68
Xtrackers World Small Cap Green Transition Innovators UCITS ETF 1C	0.51%	Equity World Small Cap Innovation	180	0.45%	3	-	LU2859297330
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0.36%	Equity United States Health Care Biotech	264	0.35%	25	-6.97%	IE00BDZVHG35
iShares Nasdaq US Biotechnology UCITS ETF	0.36%	Equity United States Health Care Biotech	264	0.35%	401	-6.88%	IE00BYXG2H39

Showing 1 to 10 of 31 entries

1 2 3 4

Order fees

Here you can find information about different brokers that allow you to trade stocks. Select your preferred order volume to compare the fees charged by the respective brokers.

Order volume:

Order fee	Stock savings plans
0.99€	1000	View offer*
0.00€	2500	View offer*
0.00€	500	View offer*
0.00€	400	View offer*
5.90€	-	View offer*

Show all offers

Source: justETF Research; As of 4/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.